The assembly and function of neuronal circuits rely on selective cell-cell interactions to control axon targeting, generate pre-and postsynaptic specialization and recruit neurotransmitter receptors. In neurons, EphB receptor tyrosine kinases mediate excitatory synaptogenesis early during development, and then later coordinate synaptic function by controlling synaptic glutamate receptor localization and function. EphBs direct synapse formation and function to regulate cellular morphology through downstream signaling mechanisms and by interacting with glutamate receptors. In humans, defective EphB-dependent regulation of NMDA receptor (NMDAR) localization and function is associated with neurological disorders, including neuropathic pain, anxiety disorders and Alzheimer's disease (AD). Here, we propose that EphBs act as a central organizer of excitatory synapse formation and function, and as a key regulator of diseases linked to NMDAR dysfunction.
Introduction
Synapses enable information flow within the central nervous system. Early during development, there is a period of new synapse addition followed by synapse maturation [1, 2] . Formation of excitatory synapses requires precise coordination between two contacting neurons to organize a presynaptic terminal capable of neurotransmitter release, and a postsynaptic specialization equipped with the proper neurotransmitter receptors [1] [2] [3] [4] . Maturation of synapses involves the pruning of inappropriate connections, stabilization of pre-and postsynaptic components and formation of appropriate morphological specializations. Finally, at the mature synapse, proper function requires synaptic maintenance and plasticity [2] . The improper formation and function of synapses can have devastating consequences. Malfunctions in synaptic formation and maturation are implicated in a wide variety of neurodevelopmental disorders, including autism spectrum disorders (ASDs). Furthermore, alterations in synaptic function contribute to neuropathic pain (see Glossary), anxiety disorders and AD [5] [6] [7] [8] [9] .
Excitatory synaptic transmission is mediated by AMPAtype [10] and NMDA-type [11] glutamate receptors. AMPA receptors (AMPARs) and NMDARs are directed to the cell surface and synaptic sites by both neuronal activity and intermolecular interactions. At synaptic sites, glutamate receptors are dynamically regulated and changes in the size and number of AMPARs and NMDARs at these sites underlie the expression of synaptic plasticity [12] [13] [14] [15] [16] . Many of the molecular mechanisms governing glutamate receptor trafficking, retention and maintenance at synaptic sites are well characterized. Especially important are associations of glutamate receptors with scaffolding proteins, such as postsynaptic density protein 95 (PSD-95) and glutamate receptor-interacting protein 1 (GRIP1), and with synaptic adhesion molecules, such as EphBs, neuroligins and epidermal growth factor receptor family members (ErbBs) [1, 3, 4] . Whereas dynamic glutamate receptor
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Glossary Allodynia: pain caused by an innocuous stimulus. Amyloid precursor protein (APP): neuronal integral membrane protein concentrated at synaptic sites. Proteolysis of APP extracellular by b-secretase 1 (BACE1) and then by g-secretase generates the 40-42 amino acid b-amyloid (Ab) found in amyloid plaques of patients with AD. Crush pain model: under deep anesthesia, a spinal nerve distal to the DRG is crushed. Thermal hyperalgesia or mechanical allodynia are then tested. DH neuron: integration of DRG inputs occurs in deep layers of spinal DH neurons. Output is carried to projection sites in the brain. DRG neuron: nociceptive afferents carrying noxious stimuli (e.g. heat, noxious cold, pressure or chemicals) have glutamatergic synapses onto relay neurons in the DRG. GTPase: small monomeric G-proteins that bind and hydrolyze GTP to GDP to stimulate downstream effectors. Guanine nucleotide exchange factor (GEF): a protein that activates small monomeric GTPase activity by accelerating the exchange of GDP for GTP. Hyperalgesia: increased sensitivity to pain. Hyperexcitability of DRG neurons: characterized by lower current threshold for action potentials, an increase in spontaneous activity and repetitive discharge. Intraplantar injection: injection into the plantar surface of the paw. Intrathecal injection: injection into the arachnoid membrane of the spinal cord. Mechanical allodynia model: the plantar surface of each hind paw is pricked with a sharp, cylindrical probe. Incidence of foot withdraw is measured. Miniature synaptic current: the postsynaptic current evoked by a single vesicle (or quanta) of neurotransmitter. Neuropathic pain: chronic pain caused by injury to the central or peripheral nervous system. Receptor tyrosine kinase (RTK): cell-surface localized single-subunit transmembrane protein with intracellular catalytic activity to autophosphorylate and then phosphorylate tyrosine residues on signaling substrates. RNAi: a method using shRNAs to bind the mRNA encoding a protein of interest to suppress its expression. Spontaneous pain model: formalin is subcutaneously injected into a hind paw. Amount of time licking, biting and flinching on the injected paw is assessed. Synaptic cell adhesion molecules: pairs of molecules that interact across adjacent cells to stabilize the initial contacts between axon and dendrite to form a synapse. They also regulate the function of existing synapses through protein-protein interactions and intracellular signaling cascades. Thermal hyperalgesia pain model: animals are placed in a testing box with a temperature-controlled floor. A heat source is then focused on the hind paw flushed to the floor and foot withdraw latency is measured.
